Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Gandrup – page 29

404 clinical trials in Gandrup, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Gandrup at a glance
404
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

404 trials in Gandrup

Open in trial search

Bronchiectasis

Not recruiting

Study on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study of RO7247669, Tiragolumab, and Atezolizumab for Patients with Untreated Advanced Urothelial Cancer Ineligible for Platinum Chemotherapy

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Enlicitide decanoate
  • Sponsor:Merck Sharp & Dohme LLC

Breast cancer

Not recruiting

Study on Adding Capecitabine to Carboplatin-Based Chemotherapy for Patients with Early Triple Negative Breast Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Skane

Study of ExPEC9V vaccine for preventing invasive E.

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ECOO15
  • Sponsor:Janssen Vaccines & Prevention B.V.

Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Type 2 diabetes mellitus+4

Not recruiting

Study on the Effects of Alendronate on Bone and Blood Sugar Markers in Patients with Diabetes and Osteopenia/Osteoporosis

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alendronate Sodium Monohydrate
  • Sponsor:Aalborg University Hospital

Study on the Effects of AZD5462 for Patients with Stable Chronic Heart Failure

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AZD5462
  • Sponsor:AstraZeneca AB

Myelofibrosis

Not recruiting

Study on Extended Access to Momelotinib for Patients with Myelofibrosis

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Momelotinib Dihydrochloride Monohydrate
  • Sponsor:Glaxosmithkline Research & Development Limited

Study Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Janssen Cilag International

Study of ibrutinib and venetoclax combination therapy for patients with relapsed or refractory chronic lymphocytic leukemia who have adequate kidney function

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Osteoarthritis

Not recruiting

Study of Diclofenac compared to Placebo for Pain Relief in Adults with Knee Osteoarthritis

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Diclofenac Sodium
  • Sponsor:NBCD A/S

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Gandrup

What the registry says about research in the country

01 Musculoskeletal Disorders

Extensive research focusing on knee osteoarthritis treatments, including innovative pain management solutions and cartilage regeneration therapies. Multiple trials are evaluating new medications and therapeutic approaches.

  • Knee Pain Management
  • Cartilage Regeneration
  • Joint Function Improvement

Studies include novel treatments like diclofenac gel and experimental compounds for pain relief and joint health.

02 Metabolic Conditions

Innovative trials addressing obesity and type 2 diabetes, with a focus on weight management therapies combined with lifestyle modifications.

  • Weight Management
  • Diabetes Control
  • Metabolic Health

Research includes dual-approach treatments targeting both weight loss and diabetic control in patients with combined conditions.

03 Cardiovascular Research

Groundbreaking studies in atherosclerotic cardiovascular disease prevention and treatment, focusing on reducing major adverse cardiovascular events.

  • Heart Disease Prevention
  • Cardiovascular Risk Management
  • Lipid Disorders

Clinical trials are evaluating new medications for preventing cardiac events in high-risk populations.

04 Neurological Conditions

Important research into Alzheimer's disease and migraine treatments, including pediatric studies for headache prevention.

  • Early Alzheimer's Intervention
  • Migraine Prevention
  • Pediatric Neurology

Trials include innovative treatments for early-stage Alzheimer's and specialized migraine therapies for young patients.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.